Laboratory assessment of liver function in people starting antiretroviral therapy with Dolutegravir or Efavirenz: a cohort study in Belo Horizonte, Brazil. (2022). Research, Society and Development, 11(13), e74111335082. https://doi.org/10.33448/rsd-v11i13.35082